Boston, MA -- (SBWIRE) -- 10/14/2015 -- GlobalData's Medical Devices sector report, "Hydrogels - Pipeline Review, 2015" provides an overview of Hydrogels currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hydrogels pipeline products.

Get More Details on this Report and a Full Table of Contents at Hydrogels - Pipeline Review, 2015

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Report Scope

-Extensive coverage of the Hydrogels under development
-The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
-The report reviews the major players involved in the development of Hydrogels and list all their pipeline projects
-The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
-The report provides key clinical trial data of ongoing trials specific to pipeline products
-Recent developments in the segment / industry

Reasons to Get this Report

The report enables you to -

-Formulate significant competitor information, analysis, and insights to improve R&D strategies
-Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
-Identify and understand important and diverse types of Hydrogels under development
-Develop market-entry and market expansion strategies
-Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
-In-depth analysis of the product's current stage of development, territory and estimated launch date

Companies Mentioned in this Report: 3QMatrix, Inc., Abeona Therapeutics, Inc., Alafair Biosciences, Inc., Asana Medical, Inc., BioCure, Inc., Biomendics, LLC, BioTime, Inc., Brigham and Women's Hospital, CelaCare Technologies, Inc., Chi2Gel Ltd., Consejo Superior de Investigaciones Cientificas, Corium International, Inc., Edixomed Ltd, FzioMed, Inc., Halscion, Inc., HyperBranch Medical Technology, Inc., InVivo Therapeutics Corporation, IPI Singapore, KeraNetics, LLC, Maxigen Biotech Inc., Medtric Biotech, LLC, Newcastle University, Northwestern University, Oculus Innovative Sciences, Inc., Oxtex Limited, Pharmagenix AG, Piramal Enterprises Limited, Plurogen Therapeutics, Inc., Quick-Med Technologies, Inc., Tel Aviv University, The Johns Hopkins University, The University of Queensland, University of Akron, University of California, San Diego, Ventrix, Inc., Zeomedix, LLC

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

-Psoriasis - Pipeline Review, H1 2015
-Depression - Pipeline Review, H1 2015
-Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015
-Hypertension - Pipeline Review, H1 2015
-Dermatitis - Pipeline Review, H1 2015